• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital
【24h】

Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital

机译：加拿大一家医院的药剂师提供的术后护理的临床收益和经济影响

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective Clinical pharmacists improve the quality of patient care by reducing adverse drug events (ADEs), length of stay and mortality. This impact is currently not well described in surgery. The objective was to evaluate clinical and economic outcomes after clinical pharmacist services were added to two general surgical wards in an adult hospital. Methods This was a prospective, observational study. All clinical interventions to resolve drug therapy problems were documented and assessed for severity, value and the probability of preventing an ADE. Cost avoidance was calculated using two methods: by avoiding additional days in hospital (CA$3593/ADE) or additional hospital costs ($7215/ADE). Two clinical pharmacy specialists and the surgical care pharmacist independently categorized the interventions; disagreements were resolved by consensus. Key findings The pharmacists made 1097 interventions in 6 months with a 98% acceptance rate by surgical staff. Half of the interventions were rated significant for severity (561, 51.1%) and value (559, 51.0%). One-quarter of the interventions had a 40% or greater probability of preventing an ADE (270, 24.6%). Cost avoidance was estimated to be $0.68-1.36 million or $617-1239 per intervention. Pharmacists avoided an additional 867 days in the hospital for surgical patients. Conclusion The pharmacist's role in the management of the drug therapy needs of the post-surgical patient has the potential to improve clinical and patient outcomes and avoid healthcare costs. The inclusion of clinical pharmacists in surgical wards may result in $7 in savings for every $1 invested.
机译：目的临床药师通过减少不良药物事件（ADE），住院时间和死亡率来提高患者护理质量。目前在外科手术中尚未很好地描述这种影响。目的是评估在成人医院的两个普通外科病房中增加临床药剂师服务后的临床和经济结果。方法这是一项前瞻性观察研究。记录所有解决药物治疗问题的临床干预措施，并评估其严重性，价值和预防ADE的可能性。避免成本的计算方法有两种：避免在医院增加住院天数（$ 3593 / ADE）或避免在医院增加住院费用（$ 7215 / ADE）。两名临床药学专家和外科护理药剂师分别对干预措施进行了分类。分歧通过协商解决。主要发现药剂师在6个月内进行了1097次干预，手术人员的接受率为98％。一半的干预措施的严重程度（561，51.1％）和价值（559，51.0％）被定为显着。四分之一的干预措施预防ADE的可能性为40％或更高（270，24.6％）。避免每次手术的费用估计为0.68-136万美元或617-1239美元。药剂师避免在医院为外科手术患者再住院867天。结论药剂师在管理术后患者药物治疗需求中的作用有可能改善临床和患者预后并避免医疗费用。将临床药剂师包括在外科病房中，每投资1美元，可以节省7美元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号